Cambrex announces the acquisition of Q1 Scientific, a leading provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, strategically located Waterford, Ireland.Learn more
East Rutherford, NJ – June 1, 2022 – Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced the acquisition of Q1 Scientific – a leading provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, […]Learn more
The Cambrex ripple represents the dynamic energy and passion of our people. It’s symbolic of the positive impacts that every employee has on our business – every day – from personal connections through to teams, departments and sites.
Our people add value to your end goals, help grow your business and we’re consistently told you enjoy working with us.
Watch our video to learn how we can accelerate your small molecule therapeutics into the market.
Cambrex is a leading global supplier of more than 100 generic APIs.
With over 40 years’ experience and a growing team of over 2,200 experts servicing our global clients from our sites in North America and Europe, we are tried and trusted in branded and generic markets for API and dosage form development and manufacturing.
Cambrex can support your project in regulated, emerging and developing markets. We are in your neighborhood, wherever you are.